Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02419976 · ClinicalTrials.gov registry record · NA
Electronic Nose Identification of Fasting and Non-fasting Breath Profiles
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 879
- Enrollment target
NCT02419976: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02419976 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 879 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02419976, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 879 participants
- Enrollment target
Study Summary
The investigators will study a noninvasive no risk process by which the investigators can quickly screen and assess for fasting and non-fasting states in individuals scheduled for routine endoscopy.
Primary Outcome
Exhaled Volatile Organic Compounds (VOCs) were collected by subject's breathing into a non-invasive breath analyzer (Aeonose) for 5 minutes by which through pattern recognition electronic changes can be identified in exhaled volatile organic compounds interfacing with an electronic sensor that creates an electronic signature, or smell-print that distinguishes the fasting and non-fasting states. The effectiveness of the Aeonose in distinguishing subjects in a fasting versus non-fasting state is r
Interventions
- OTHER a breath analysis using the Aeonose
- DEVICE Aeonose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 879 participants |
| Start Date | 2015-02 |
| Est. Completion | 2024-06-20 |
| Phase | NA |
Why NCT02419976 stopped before completion
NCT02419976 is an interventional study that assigns participants to a tested intervention. The registered 879 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (37% lower).
The record links to 0 conditions, and to 2 interventions - of which a breath analysis using the Aeonose is the first listed.
NCT02419976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02419976 about?
NCT02419976 is a clinical study titled "Electronic Nose Identification of Fasting and Non-fasting Breath Profiles". The investigators will study a noninvasive no risk process by which the investigators can quickly screen and assess for fasting and non-fasting states in individuals scheduled for routine endoscopy.
What is the current status of trial NCT02419976?
This trial is currently terminated. It is a NA study. The enrollment target is 879 participants. The study started on 2015-02. Estimated completion is 2024-06-20.
What interventions are being tested in trial NCT02419976?
The interventions under investigation include: a breath analysis using the Aeonose (OTHER), Aeonose (DEVICE).
Who is sponsoring clinical trial NCT02419976?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02419976's enrollment target sits among peer trials
879 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
- NCT05525663 · 880 participants · NA
Physical Rehabilitation for Older Patients With Acute Heart Failure With Preserved Ejection Fraction
- NCT06580314 · 880 participants · Phase 3
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia